Last reviewed · How we verify
Form 2 of AZD5718 tablets
Form 2 of AZD5718 tablets is a Small molecule drug developed by AstraZeneca. It is currently in Phase 1 development.
At a glance
| Generic name | Form 2 of AZD5718 tablets |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Form 2 of AZD5718 tablets CI brief — competitive landscape report
- Form 2 of AZD5718 tablets updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Form 2 of AZD5718 tablets
What is Form 2 of AZD5718 tablets?
Form 2 of AZD5718 tablets is a Small molecule drug developed by AstraZeneca.
Who makes Form 2 of AZD5718 tablets?
Form 2 of AZD5718 tablets is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
What development phase is Form 2 of AZD5718 tablets in?
Form 2 of AZD5718 tablets is in Phase 1.
Related
- Manufacturer: AstraZeneca — full pipeline
- Compare: Form 2 of AZD5718 tablets vs similar drugs
- Pricing: Form 2 of AZD5718 tablets cost, discount & access